Genetics and molecular pathology of Stargardt-like macular degeneration
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Stargardt-like macular degeneration (STGD3) is an early onset, autosomal dominant macular degeneration. STGD3 is characterized by a progressive pathology, the loss of central vision, atrophy of the retinal pigment epithelium, and accumulation of lipofuscin, clinical features that are also characteristic of age-related macular degeneration. The onset of clinical symptoms in STGD3, however, is typically observed within the second or third decade of life (i.e., starting in the teenage years). The clinical profile at any given age among STGD3 patients can be variable suggesting that, although STGD3 is a single gene defect, other genetic or environmental factors may play a role in moderating the final disease phenotype. Genetic studies localized the STGD3 disease locus to a small region on the short arm of human chromosome 6, and application of a positional candidate gene approach identified protein truncating mutations in the elongation of very long chain fatty acids-4 gene (ELOVL4) in patients with this disease. The ELOVL4 gene encodes a protein homologous to the ELO group of proteins that participate in fatty acid elongation in yeast. Pathogenic mutations found in the ELOVL4 gene result in altered trafficking of the protein and behave with a dominant negative effect. Mice carrying an Elovl4 mutation developed photoreceptor degeneration and depletion of very long chain fatty acids (VLCFA). ELOVL4 protein participates in the synthesis of fatty acids with chain length longer than 26 carbons. Studies on ELOVL4 indicate that VLCFA may be necessary for normal function of the retina, and the defective protein trafficking and/or altered VLCFA elongation underlies the pathology associated with STGD3. Determining the role of VLCFA in the retina and discerning the implications of abnormal trafficking of mutant ELOVL4 and depleted VLCFA content in the pathology of STGD3 will provide valuable insight in understanding the retinal structure, function, and pathology underlying STGD3 and may lead to a better understanding of the process of macular disease in general.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454 · cited 1×
“Neurodegenerative diseases, such as Alzheimer disease, Parkinson disease, and retinitis pigmentosa, belong to a group of protein misconformation disorders that are associated with accumulation of abnormal protein aggregates in cells (Saliba et al., 2002; Ross and Poirier, 2004).”
BackgroundCauses and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · cited 2×
“In addition, a number of gene variants associated with AMD, such as specific complement factor-H and B (CFH and CFB) alleles among others, have been identified that modify the risk for developing AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006; Yates et al., 2007; Swaroop et al.,…”
BackgroundComplement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 2×
“In addition, a number of gene variants associated with AMD, such as specific complement factor-H and B (CFH and CFB) alleles among others, have been identified that modify the risk for developing AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006; Yates et al., 2007; Swaroop et al.,…”
BackgroundAggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148 · cited 1×
“Formation of Wt/mutant ELOVL4 aggresomes is evident by the reorganization of themajor cytoskeletal elements, vimentin, and colocalization of ELOVL4 aggregates with g-tubulin, a marker of the microtubule organization center (Johnston et al., 1998).”
BackgroundRNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357 · cited 1×
“Inhibition of mutant gene expression can be achieved by a variety of approaches, including antisense, ribozymes, and, more recently, RNA interference (RNAi) (Hauswirth et al., 2000; LaVail et al., 2000; Bumcrot et al., 2006; Zimmermann et al., 2006).”
BackgroundDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208 · cited 2×
“Drusen, the earliest sign of AMD, is an accumulation of extracellular deposits that contains lipofuscin and other proteins (Ben-Shabat et al., 2001; Johnson et al., 2001; Penfold et al., 2001; Ben-Shabat et al., 2002; Barthes et al., 2005; Bressler et al., 2005; Umeda et al., 2005; Crabb et al., 2002; Sakaguchi et al.…”
BackgroundThe AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075 · cited 2×
“In addition, a number of gene variants associated with AMD, such as specific complement factor-H and B (CFH and CFB) alleles among others, have been identified that modify the risk for developing AMD (Edwards et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006; Yates et al., 2007; Swaroop et al.,…”
BackgroundNrl is required for rod photoreceptor development
Mears, A. J., Kondo, M., Swain, P. K., Takada, Y., Bush, R. A., Saunders, T. L., Sieving, P. A., & Swaroop, A. (2001) · Nature Genetics · doi:10.1038/ng774 · Cited by 912
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 2×
“…entire retina and not just themacular region, and there have been a number of successes in showing that incorporation of known humanmacular disease genes or mutations into mice result in retinal disease (Weng et al., 1999; Mears et al., 2001; Ambati et al., 2003; Marmorstein and Marmorstein, 2007).”
Background
Cited by
Very long-chain fatty acids: elongation, physiology and related disorders
Kihara, A. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs105 · Cited by 441
Metabolism of Very Long-Chain Fatty Acids: Genes and Pathophysiology
Sassa, T., & Kihara, A. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.017 · Cited by 302
“STDG3 is caused by mutations in the ELOVL4 gene on chromosome 6 (Table 2) (Zhang et al., 2001; Vasireddy et al., 2010).”
Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein
Agbaga, M.-P., Mandal, M. N. A., & Anderson, R. E. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r005025 · Cited by 167
Ozaki, K., Doi, H., Mitsui, J., Sato, N., Iikuni, Y., Majima, T., Yamane, K., Irioka, T., Ishiura, H., Doi, K., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0610 · Cited by 81
Dwyer, M. A., Kazmin, D., Hu, P., McDonnell, D. P., & Malek, G. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0392 · Cited by 61
Metadata
- Authors
- Vasireddy, V., Wong, P., & Ayyagari, R.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 29
- Issue
- 3
- Pages
- 191-207
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2085852663
- Cited by
- 68
- References
- 28
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetics and molecular pathology of Stargardt-like macular degeneration. https://app.cochat.ai/papers/10.1016/j.preteyeres.2010.01.001
- The paper
- Vasireddy, V., Wong, P., & Ayyagari, R. (2010). Genetics and molecular pathology of Stargardt-like macular degeneration. Progress in Retinal and Eye Research. https://doi.org/10.1016/j.preteyeres.2010.01.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.